Two Sigma Investments’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Two Sigma Investments’s Portfolio AZR Stock Details AZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-432	Closed	-$3.26K	–	3633
2025 Q2	$3.26K	Buy	+432	New	+$6.52K	﹤0.01%	3148
2023 Q3	–	Sell	-28	Closed	-$3.67K	–	2933
2023 Q2	$3.67K	Hold	28	–	–	﹤0.01%	2962
2023 Q1	$6.2K	Sell	28 -65	-70%	-$15.8K	﹤0.01%	2907
2022 Q4	$12.6K	Hold	93	–	–	﹤0.01%	2718
2022 Q3	$20K	Buy	+93	New	+$41.9K	﹤0.01%	2379
2019 Q2	–	Sell	-41	Closed	-$87K	–	3275
2019 Q1	$87K	Buy	41 +22	+116%	+$65.5K	﹤0.01%	2908
2018 Q4	$60K	Buy	+19	New	+$30.4K	﹤0.01%	2855

Other funds holding AZR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Two Sigma Investments's AZR Position: Q3 2025 in Review

Two Sigma Investments sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q3 2025, closing a stake of 432 shares — an estimated $3.26K sold.

Two Sigma Investments first reported a position in AZR in Q4 2018 and held it in 7 quarters. The position peaked at $87K in Q1 2019. 17 funds tracked by Wall St. Rank hold AZR as of Q3 2025.

Two Sigma Investments reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Two Sigma Investments sold 432 Azora Therapeutics, Inc. Common Stock shares in Q3 2025, an estimated $3.26K.
Two Sigma Investments first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Two Sigma Investments's Azora Therapeutics, Inc. Common Stock position peaked at $87K in Q1 2019.
17 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.